Professional Documents
Culture Documents
Abstract
Background: Coronary heart disease (CHD) is one of the leading causes of death worldwide. Scientific literature
shows that prevention of CHD is inadequate. The clinical pharmacist’s role in patient-centred care has been shown
favourable in a large amount of studies, also in relation to reduction of risk factors related to CHD. We developed
and piloted a pharmacist-led follow-up program for patients with established CHD after hospital discharge from a
hospital in North Norway. The aim of the present study was to explore how participants in the follow-up program
experienced the program with regard to four main topics; medication knowledge, feeling of safety and comfort
with medications, the functionality of the program and the clinical pharmacist’s role in the interdisciplinary team.
Methods: We performed semi-structured thematic interviews with four patients included in the program. After
verbatim transcribing, we analysed the interviews using “qualitative content analyses” by Graneheim and Lundman.
Trial registration www.clinicaltrials.gov: NCT01131715.
Results: All participants appreciated the follow-up program because their medication knowledge had increased,
participation had made them feel safe, they were reassured about the appropriateness of their medications, and
they had become more involved in their own medication. The participants reported that the program was well
structured and the clinical pharmacist was said to be an important caretaker in the health-care system. The importance
of collaboration between pharmacists and physicians, both in hospital and primary care, was emphasized.
Conclusion: Our results indicate that the follow-up program was highly appreciated among the four participants
included in this study. The results must be interpreted in the context of the health care system in Norway today.
Here, few pharmacists are working in hospitals or in close relation to the general practitioners. In addition,
physicians are short of time in order to supply appropriate medication information, both in hospital and primary
care. Involving pharmacists in follow-up of patients with CHD seems to be highly appreciated among patients and
may be a step towards improving patient care. The study is limited by the low number of participants.
Keywords: Qualitative study, Patient experience, Follow-up program, Clinical pharmacist, Coronary heart disease
© 2014 Garcia et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Garcia et al. BMC Research Notes 2014, 7:197 Page 2 of 9
http://www.biomedcentral.com/1756-0500/7/197
local preventive cardiology programs adapted to individ- meeting) or by phone or letter (the two last meetings).
ual countries is needed in order to care for coronary and After each meeting, patients received a written sum-
high-risk patients [4]. mary from the meeting in addition to laboratory results,
A growing body of studies now indicates that involve- correct medication list, information about the specific
ment of the clinical pharmacist in direct patient care im- medications they were using, and individual instruc-
proves medical therapy and patient outcomes relevant to tions. The general practitioner (GP) received a letter
secondary prevention of CHD, for example blood pres- with laboratory values, identified drug-related problems
sure, blood lipids, prescription of cardioprotective drugs and recommendations on how to handle these.
[5-10]. Despite this, few follow-up programs for patients
with CHD described in literature, involve the clinical Enrolment of participants
pharmacist as a one of the main stakeholders. Taveira et Participants in the follow-up program that had met with
al. describes a Pharmacist-Led Cardiac Risk Reduction the clinical pharmacist at least twice were eligible for in-
Clinic (CRCC) in the USA, where risk reduction in clusion if they were living within the city boundary of
terms of Framingham risk score for CHD was reduced Tromsø. Because of the limited time available for the
in patients participating in the CRCC [11,12]. Reilly and masters project, we aimed to include at least four to six
Cavanagh describe a successful pharmacist-nurse-run participants. In the period February-March 2010 the
clinic for patients with cardiovascular disease in terms of clinical pharmacist handed out written information
optimizing drug and lifestyle therapy [13]. Lee et al. about the study to eligible patients at the end of the con-
showed positive effect of a pharmacy care program (FAME) sultation. To conceal patient participation for the
in terms of increased medication adherence, medication pharmacist, the patients were asked to read the informa-
persistence and clinically meaningful reductions in blood tion at home and to return the signed consent paper to
pressure [14]. a third party by normal mail. A pre-paid envelope was
At the University Hospital in North Norway, a new supplied. To avoid including more than the estimated
follow-up program for patients with established CHD number of participants, the pharmacist recruited pa-
was developed and piloted during 2009-2011 (unpub- tients in blocks of four. If a sufficient number was not
lished data). The program was run by a clinical pharma- included after one recruitment block, the pharmacist
cist. The intervention group receiving follow-up finally was asked to repeat the procedure. The enrolment pro-
included 49 patients. Few studies have explored patient cedure was repeated four times in total, ending in March
experience with pharmacist involvement in patient care, 2010 when five patients had returned their consent pa-
though high satisfaction have been observed [15-20]. We pers. These patients were contacted by phone and a
aimed to explore the experience of participating patients face-to-face interview was arranged. Participants were
in the follow-up program. We chose to use a qualitative free to choose whether the interview should be held in
approach with semi-structured interviews, because ques- their home or at the Department of Pharmacy (close to
tionnaires do not widely allow for elaboration of an- the hospital). One participant withdrew before the inter-
swers. The study was performed by an undergraduate view because of sudden illness. Finally, two males and
masters student in Pharmacy, and formed basis for his two females were interviewed. They were aged 47, 57, 62
masters thesis in 2010 [21]. and 71 years.
receiving from the clinical pharmacist?” Participants were with medication’ was merged with the topic ‘experiences
encouraged to speak freely, in order to capture the narra- with the follow-up program’, based on the finding that
tive. The interviewer asked questions rooted in the main all four participants expressed that the program itself
topics to elaborate, clarify and confirm understanding. had made their ‘feeling of safety and comfort with medica-
Interviews were held during February and March 2010. tions’ increase. In Table 1, the findings from the analysis
None of the interviewees chose to perform the interviews are shown. In the following sections, condensed versions
at home. Interviews lasted 40-60 minutes, were audio- of the three final topics are given. The informants are re-
taped and transcribed verbatim by the interviewer directly named Steve (62 years) , Bryan (47 years), Claire (57 years)
afterwards. Field notes were taken. To ensure that both and Mary (71 years).
the manifest and the latent content were reflected in the
narratives, the interviews were listened to several times
during the transcription phase. The narratives were subse- Experiences with the follow-up program
quently “washed”, meaning that all sentences were struc- Experiences with the follow-up program were found to
tured to make sense and extra words were omitted. be characterized by its framework and execution, the
Quotes were subsequently translated into English by the pharmacist’s performance and her empathic behaviour.
principal investigator (BHG). Translation was verified by In addition, all participants said that the program had
the co-authors. To give feedback on interviewing tech- made them feel more safe and comfortable with their
nique and content, the whole research group read thor- medications. These experiences were categorized into
oughly through the first narrative before the next ‘specific’ and ‘abstract’ experiences, the latter category
interview was held. The whole research group read all in- covering feelings and personal opinions.
terviews before data analysis. The informants described the follow-up program with
words like ‘great’, ‘a positive experience’, ‘educative’, that
Data analysis they felt ‘safeguarded’ and ‘fortunate’, that they had ‘re-
An initial analysis was performed by the master student ceived special treatment’ and ‘help in daily life’. All four
using the thematic approach described as ‘qualitative informants stated that the follow-up program should be
content analysis’ by Graneheim and Lundman [22]. This recommended to everybody that uses medications. Steve
approach comprises the following elements: i) reading of suggested that everybody using medications should be
all texts several times in order to obtain a sense of the
whole; ii) identifying units of analysis in accordance with Table 1 Results from ‘qualitative content analysis’ of four
the main topics and bringing these into texts; iii) identi- narratives; topics, main-categories and sub-categories
fying meaning units and abstracting these into condensed Topic Main-categories Sub-categories
meaning units; iv) labelling the condensed meaning units Experiences with the Abstract Feelings of safety
follow-up program
with a code; v) comparing the codes concerning similar- Personal opinions about
ities and differences and sorting them into main-categories the pharmacist and the
framework
and sub-categories, which constitute both the manifest
and the latent content of the interviews, vi) summarizing Specific Medication
the contents of the main categories to generalized descrip- Execution
tions and experiences reflecting the most important as- Clinical pharmacist
pects of each topic in the interview guideline. The same performance
analysis was subsequently made by the principal investiga- Knowledge about Insight Use
tor (BHG), and validated by the research team (SLS, LS), medications
Importance
who agreed upon the final interpretation. Medication properties
Attitude towards Adherence
Ethics medications
Concordance
This study has been conducted in accordance with the
principles of the Helsinki Declaration [23]. Informed con- The clinical pharmacist’s Primary care General practitioner
role in the interdisciplinary
sents were obtained from all participants and the Regional team Clinical pharmacist
Committee for Medical Research Ethics North Norway Community pharmacies
approved the study. Registration number at www.clinical- Hospital care Hospital ward
trials.gov is NCT01131715.
Heart school
Ideal collaboration Clinical pharmacist
Results task
The four initial main topics were eventually reduced to
Overall
three topics. The topic ‘feeling of safety and comfort
Garcia et al. BMC Research Notes 2014, 7:197 Page 4 of 9
http://www.biomedcentral.com/1756-0500/7/197
offered pharmacist counselling at least once per year. seemed to be related to both the pharmacist’s profes-
Claire described it like this: sional skills as well as the predictability of the follow-up
program. The fact that the pharmacist supplied a ‘second
“You don’t get enough information about medicines. opinion’ about the medications, the availability of the
So, you’ve really made a discovery with this program! pharmacist by phone, and the honest answers to ques-
Everybody using medications, or at least everybody tions also seemed to contribute to the feeling of being
who use medications after hospitalization, and who cared for. Consequently, this made participants feel safe.
has to use medications life-long, should have this kind That the participants felt safe while participating in this
of follow-up” (Claire) [1] program seemed to be related to their feeling of not be-
ing properly taken care of by the public health care sys-
All participants expressed that they had gained new tem. Claire said:
and clarifying information about their medication.
Claire, Mary and Bryan even believed that their medica- “If I had not joined this program, I would have been
tion regime had become better and more appropriate. all on my own” (Claire) [4]
All participants appreciated the pharmacist’s thorough
knowledge about medications and her critical attitude
towards them, which can be explained by the general Knowledge about medications
scepticism towards medications expressed by all four All participants said that they had gained knowledge
participants. In fact, It seemed like they most of all did about medications in some way or another. They had in-
not want to use medications, or at least wanted to keep creased their knowledge within the following topics:
them at a minimum. In addition to the pharmacist’s pro- ‘medication use’, ‘how to take medications’ and ‘their own
fessional skills, the emphatic way of acting with patients attitude towards medicines’. The latter category could be
played an important role when educating about medica- dichotomized into the well-known principles within phar-
tions. Mary said: macy; ‘adherence’ and ‘concordance’, respectively reflecting
‘The extent to which the patient’s behaviour matches
“She was a human being that I could talk to. One that was agreed recommendations from the prescriber’ and ‘a
professionally educated, who was skilled in supervising consultation process, in which doctor and patient agree
me about my medications and my disease” (Mary) [2] upon therapeutic decisions that incorporate their re-
spective views’ [24,25].
How the follow-up program was carried out seemed Knowledge gained by participants seemed to be founded
important to the participants. The following elements in the thorough and comprehensible information given by
were highlighted: the generous time schedule during the pharmacist, which was highlighted by all informants.
follow-up, the proximity to the place where meetings Mary stated:
took place, and the fact that they received summary let-
ters and copies of correspondence with the GP. “She explained in a manner so that I understood like
Bryan and Steve also preferred personal meetings over I’d never done before” (Mary) [5]
phone meetings. They said that it established a closer re-
lationship with the pharmacist and that they could de- This shows the importance of communication skills
vote themselves fully to the follow-up issues without and communicating with patients in a language they
being disturbed. Mary and Bryan also felt that the understand. Claire said she had become more adherent
follow-up program had been presented to them in a re- with her medication regime, as she now recognized the
spectful way, not ‘like a salesman’ as Bryan stated it. importance of her medications. Steve and Bryan said
Claire, Bryan and Mary also appreciated that they did they had become more conscious about their medication
not have to keep track on so many things during follow- use, which indicates a higher understanding, which is
up, as Bryan announced: one of the cornerstones of ‘the concordance principle’.
Everybody expressed that they had acquired specific
“If I would have to write a diary, journal or knowledge, either about the correct time of the day to
remember anything in particular, like sending in take medications (for example simvastatin at night in
reports or whatever… I doubt that I would have order to obtain optimal effect), important food-drug in-
joined–I’m so bad in keeping track of such things”. teractions (for example calcium absorption may be
(Bryan) [3] inhibited by dietary fibre) or the drugs’ intended effect
(for example β-blockers to slow your heart rate). Claire
All four informants said that they felt safe when being and Steve also felt they had acquired knowledge about
part of the follow-up program. The feeling of safety side effects (for example that ‘aspirin may be hard for
Garcia et al. BMC Research Notes 2014, 7:197 Page 5 of 9
http://www.biomedcentral.com/1756-0500/7/197
your stomach’ and ‘simvastatin may give you muscle offering a ‘second opinion’ of their medications. Steve
pain’). For Bryan, the information from the clinical said:
pharmacist had made him aware that he actually had
side effects from his β-blocker: “I think it’s reasonable that a pharmacist has an
overview parallel to the physician’s, and perhaps also
“And it struck me as a lightening, the cause of all my has a different view on things” (Steve) [8]
troubles. They were side effects of the medications I
was using, sweating, headache, no energy, heart rate Bryan, Claire and Mary told that their GPs had appre-
under 40 and very lazy…” (Bryan) [6] ciated and welcomed the pharmacist’s medication rec-
ommendations. Mary said that she had actually feared a
Bryan also told that he previously took his medications negative reaction from her GP, and indicated that GPs
because his doctor told him so. The other participants might experience pharmacist involvement as interfering
indicated similar attitudes, which is the opposite of the with their area of expertise.
‘concordance principle’. The fact that they all empha- The participants regarded community pharmacies like
sized how important knowledge about medication was more or less “normal shops”, where ‘you hand in your
indicates that they were pleased with approaching ‘con- prescription, you pay and you leave’, as Bryan stated.
cordance’. Mary said: Claire said that the follow-up from the clinical pharma-
cist was something totally different and that she had
“It’s positive to know more about what you put in never experienced to get information from pharmacists
your mouth and swallow with water… and believe in a community pharmacy. She now wanted the com-
that this helps for this and that. But to know why munity pharmacists to be more available and visible in
it helps and how… that’s what I think is positive. the pharmacies. Steve also felt that it would be easier to
That you learn more about it, not just eat and approach community pharmacists after the follow-up
swallow what the doctor has told you to.” program.
(Mary) [7] The clinical pharmacist’s role in the hospital service
was acknowledged by all participants, and must also be
seen in relation with their disappointment concerning
The clinical pharmacist’s role in the interdisciplinary team follow-up from their hospital. Involvement from a
The participants’ experiences with the pharmacist as part pharmacist at the ward was regarded as positive because
of the interdisciplinary team, was frequently expressed in of the pharmacists’ skills within medication counselling.
comparison with their experiences with the public health- Again, this must be seen in relation to the physicians’
care service in general; the GP, the hospital and the com- shortage of time. Mary said:
munity pharmacies. Our findings have to be seen in the
light of the Norwegian healthcare system, where patients “I think that having a pharmacist at the hospital ward
are not familiar with encountering clinical pharmacists. would be very good. They can explain about
Consequently, they compare their experience with the medication use, because the doctors, unfortunately,
follow-up program with the healthcare service they nor- don’t have time for that” (Mary) [9]
mally receive.
All four participants expressed that time with and in- Steve also had thoughts about ‘the Heart School’,
formation from their GP was inadequate. They said that which is a two-day follow-up program offered by the
the pharmacist had been more available for questions. University Hospital of North Norway to patients that
Bryan called the GP system an ‘on-going industry’. His have experienced their first myocardial infarction. The
argument was that that he always exited the physician’s program comprises group teaching by a cardiologist
office within ten minutes after entering, including pay- about CHD, by a pharmacist about medications, by a
ment, feeling that the consultation is too short. Mary physiotherapist about physical activity and by a nutrition-
thought that explanations she received from her physi- ist about diet and heart-protective food. The patients also
cians were of poor quality. In fact, when the participants receive a one-to-one consultation with the cardiologist.
spoke about their GPs, they all expressed feelings like Steve suggested that the pharmacist should also perform
‘lack of confidence’, ‘not being taken seriously’ and ‘given one-to-one consultations, in the same manner as the car-
a prescription to end the appointment’. Seen in the light diologist. He said:
of such experience, it is perhaps not strange that they
appreciated the pharmacist’s suggestions medication “You have the physiotherapist and the expert in
amendments, and that they acknowledged the pharma- nutrition. You have the cardiologist, and you have the
cist as part of the interdisciplinary team as the one pharmacist. Those four are important, I believe… and
Garcia et al. BMC Research Notes 2014, 7:197 Page 6 of 9
http://www.biomedcentral.com/1756-0500/7/197
I’ve experienced that, at the Heart School…. Those to their experience of shortage of time by healthcare
four should form a team. The result will be a better professionals in general. Tsiantou et al. also found that
understanding of the relationship between time spent by pharmacist in patient relationships was as
medications, diet, physical activity and stress. [….] It’s an important factor in order to increase medication ad-
important that the patients with coronary heart herence [18].
disease get to speak with the pharmacist. This may be But time was not the only factor that contributed to
feasible at the Heart School. Time for personal the participants’ positive experience with the follow-up
consultations with the pharmacist must be a priority” program. As also mentioned by Tsiantou et al. and
(Steve) [10] Lalonde et al., participants were interested in deeper
and more comprehensible information to increase their
Altogether, pharmacist collaboration with the GP and understanding of their medications, as this had not been
the hospital physician were appreciated and seen as im- offered by their GP’s [15,18]. All participants expressed
portant, both to inform about mediation, and to perform critical attitudes towards medications, which may be one
‘quality checks’ of medication regimens. Claire thought reason why the ‘second opinion’ from the pharmacist
that all patients at a cardiology ward should meet the seemed to be of great importance. This ‘second opinion’
pharmacist before discharge. Steve was also convinced had also made them feel comfortable and safe with their
about the economy in this; he thought this could make a medication regime. The pharmacist’s ability to identify
means to get patients more rapidly back to work. Con- inappropriate prescribing and drug-related problems
cerning medication dispensing at the community phar- through medication therapy reviews is widely recognized
macy, Steve found it troublesome if he had to return to and embraced by the philosophy of pharmaceutical care
his GP for a new prescription because the pharmacist re- [26-29]. This also corresponds to the participants’ ac-
vealed a drug related problem. This indicates that medi- knowledgement of the pharmacist’s involvement in quality
cation therapy review should be performed at the time checking medication regimes.
of prescription. Non-adherence to medications use has been shown to
Despite the positive endorsement of the pharmacists’ be one of the most important factors for therapy failure
role in the interdisciplinary health-care team, there were [30]. In our study, participants stated that they had be-
concerns raised by the participants regarding how differ- come more adherent to their medication regimes as their
ent tasks should be distributed between the different level of knowledge had increased. They were also inter-
members of the healthcare team. In addition, the concern ested in taking part in decision making in relation to their
for the patient having too many healthcare professional to medications; not only obeying their doctors. It might seem
relate to was also mentioned. Steve said: like adherence with the GP’s prescribing was replaced with
the principle of ‘concordance’ during the follow-up pro-
“I believe the patients will benefit from the gram. However, this needs further investigation.
collaboration between the physician, the pharmacist According to our findings, pharmacists should be in-
and the nurse–if it’s done properly. However, the volved in patient care at different levels; medication in-
patient cannot relate with too many persons. It might formation to patients, collaboration with physicians in
not be necessary for the pharmacist to have their own medication-related questions and quality check of drug
consultations with the patients at the ward, but the regimens (both at hospitals and in community care),
physician must use the pharmacists’ knowledge more and individual medication consultations, for instance at
than today… I’m sure they [the pharmacists] have the ‘Heart School’. In general, pharmacists were ac-
more knowledge about medicines than the physicians. knowledged to have more thorough knowledge about
But the specific way to go forward can be medicines compared to physicians. In other countries,
troublesome… to find the middle way.” (Steve) [11] for instance in the USA and the UK, pharmacists are
already participating in these kind of activities, which
Discussion has been shown to improve health-related outcomes
Applying a thematic approach, this study is the first [31]. It was however surprising that the community
study to explore experiences from patients with estab- pharmacy were disregarded as a place for drug informa-
lished CHD with a pharmacist-led one-year follow-up tion, and only acknowledged as a place for drug dis-
program after hospital discharge. All participants highly pensing. This is contradictory to the Norwegian legal
appreciated the program, which is in accordance with framework of the pharmacies, where the role concern-
findings from other studies where satisfaction with ing medication information is emphasized [32]. This
pharmacist involvement in direct patient care has been perception needs further investigation, as this will be
explored [15,17,19]. Time seemed to be an important crucial for further development of patient-centred com-
factor for all participants, which must be seen in relation munity pharmacy services.
Garcia et al. BMC Research Notes 2014, 7:197 Page 7 of 9
http://www.biomedcentral.com/1756-0500/7/197
Despite a consistent positive attitude to the pharma- and context of the experience under investigation between
cist as part of the health-care team, we need to take into informants, interviewer and analysing process) [34]. This
account that participants were concerned about how has to be interpreted by the reader in the light of our de-
the pharmacist-physician collaboration should function scriptions. v) The second analysis was performed by the
without friction. The fact that pharmacists are not fully PI, who was the clinical pharmacist during the follow-up
acknowledged as part of the interdisciplinary team in program. Recall bias has been minimized by concealing
Norway today may have contributed to this finding. It patient identity and performing the second analysis more
will be essential to clarify the clinical pharmacist’s role than twelve months after the end of the follow-up pro-
in the healthcare team, allowing patients to know gram. Nevertheless, the analysis may be biased by personal
exactly what to expect from the different health-care perceptions and negative patient experiences with the
personnel. follow-up program may be concealed. Because the narra-
tives were analysed twice by different persons and vali-
dated by the research group, we have sought to diminish
Credibility also this bias.
“Credibility deals with the focus of the research and re-
fers to confidence in how well data and processes of ana-
Dependability
lysis address the intended focus” [22]. In our study,
Dependability concerns “the degree to which data change
several elements need to be considered: i) The number
over time and alterations made in the researcher’s deci-
of informants may not have been sufficient to embrace
sions during the analysis process” [22]. Our data com-
all aspects of the follow-up program and a larger study
prised four narratives that were collected during a relative
may have shown more variation in findings. However,
short period of time. The time factor is not considered
the four main topics were explored and elaborated satis-
crucial in relation to the content of the interviews. The
factory by all participants. The results of a qualitative
interviewer may have changed his interviewing technique
study cannot be generalized in the same way as in quan-
slightly from interview to interview, which is considered
titative studies. The study has, however, shown what it
one of the hallmarks of good qualitative methodology;
may be like to be in the follow-up program–an insight
variability rather than standardization, also called flexibility
that in itself may enrich our body of knowledge and also
[34]. It is, however, important that flexibility is considered
initiate new research questions. ii) The interviews fo-
alongside reflexivity [34]. In this case, that the interviewer
cused on four main topics, which is also reflected in the
was an undergraduate pharmacist student, inexperienced
findings above. The narrative approach was important,
in qualitative interviewing and possibly biased by the fact
and a semi-structured interview-guide was supposed to
that he thought this program was positive. If the inter-
allow the participants to tell their own story in their
viewer for instance had a different professional background,
own words. We wanted to gain knowledge concerning
had more experience or was negative towards such a pro-
the main topics, but also concerning other relevant as-
gram, results might have been different and other aspects
pects not covered by the main topics. We realize that
of the program may have been revealed.
focus on the main topics may have been too strong to
allow for the latter to happen. iii) The interviews were
performed at the Department of Pharmacy. Dahlberg ar- Transferability
gues that interviews in the participants’ homes is experi- Transferability refers to “the extent to which the findings
enced as safer and more Comfortable [33]. Consequently, can be transferred to other settings or groups” [22]. We
we might have gained more knowledge if interviews were only included patients with CHD, who were participants
performed in the participants’ home. (iv) Verbatim tran- of the follow-up program. Our results consequently re-
scribing of the interviews was done in ‘bokmål’, which was flect our new knowledge concerning this particular pa-
neither spoken by the informants nor by the interviewer. tient group and this particular follow-up program.
This may have introduced misunderstandings. We did try However, as CHD is the number one disease worldwide,
to diminish this by listening to the text several times dur- and also frequently co-morbid to other diseases, for ex-
ing transcription. Additionally, quotes have been trans- ample diabetes, renal failure and chronic obstructive
lated from Norwegian to English, which again may have pulmonary disease (COPD), our findings may be applic-
introduced ambiguity in interpretation. This was sought able also in other patient groups. However, this remains
diminished by verifying translation by several parts. to be explored. It is said that “the most useful indicator
Nevertheless, some degree of interpretation cannot be of credibility of the findings is when the practitioners
avoided because qualitative research is a product of reflex- themselves and the readers of the theory view the study
ivity (that fact that the researcher’s pre-understanding and findings and regard them as meaningful and applicable
decisions will inevitable have impact upon the meaning in terms of their experience” [35].
Garcia et al. BMC Research Notes 2014, 7:197 Page 8 of 9
http://www.biomedcentral.com/1756-0500/7/197